FOXN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.764200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.054400E-01
Normal-vs-Stage2
5.006000E-01
Normal-vs-Stage3
2.343600E-01
Normal-vs-Stage4
6.406400E-01
Stage1-vs-Stage2
9.788000E-01
Stage1-vs-Stage3
2.070100E-02
Stage1-vs-Stage4
4.189800E-01
Stage2-vs-Stage3
1.9828899999963E-05
Stage2-vs-Stage4
4.211400E-01
Stage3-vs-Stage4
5.078200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.809600E-01
Normal-vs-AfricanAmerican
4.831800E-01
Normal-vs-Asian
2.952400E-01
Caucasian-vs-AfricanAmerican
5.167800E-01
Caucasian-vs-Asian
3.042000E-03
AfricanAmerican-vs-Asian
3.211700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.754800E-01
Normal-vs-Female
4.787200E-01
Male-vs-Female
9.553000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.865800E-01
Normal-vs-Age(41-60Yrs)
6.135000E-01
Normal-vs-Age(61-80Yrs)
4.276800E-01
Normal-vs-Age(81-100Yrs)
4.016400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.809600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.659800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.707600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.957200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.634400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.574200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.063840E-01
Normal-vs-Daily Drinker
4.230400E-01
Normal-vs-Weekly Drinker
1.935240E-01
Normal-vs-Occasional Drinker
4.932200E-01
Normal-vs-Social Drinker
2.610600E-01
Non Drinker-vs-Daily Drinker
8.272400E-01
Non Drinker-vs-Weekly Drinker
8.035000E-01
Non Drinker-vs-Occasional Drinker
6.478000E-01
Non Drinker-vs-Social Drinker
5.494800E-01
Daily Drinker-vs-Weekly Drinker
9.351000E-01
Daily Drinker-vs-Occasional Drinker
5.040000E-01
Daily Drinker-vs-Social Drinker
4.364000E-01
Weekly Drinker-vs-Occasional Drinker
5.652800E-01
Weekly Drinker-vs-Social Drinker
5.161000E-01
Occasional Drinker-vs-Social Drinker
8.533400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.470600E-01
Normal-vs-Grade 2
3.521800E-02
Normal-vs-Grade 3
3.696400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.627760E-02
Grade 1-vs-Grade 3
9.356600E-03
Grade 1-vs-Grade 4
2.470600E-01
Grade 2-vs-Grade 3
3.715000E-01
Grade 2-vs-Grade 4
3.521800E-02
Grade 3-vs-Grade 4
3.696400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.032810E-01
Normal-vs-NonDiabetic
4.442800E-01
Diabetic-vs-NonDiabetic
9.889000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.807000E-01
Normal-vs-NoPancreatitis
4.623800E-01
Pancreatitis-vs-NoPancreatitis
3.677600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.281800E-01
Normal-vs-N1
5.101600E-01
N0-vs-N1
1.655160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.407800E-01
Normal-vs-TP53-NonMutant
1.525760E-01
TP53-Mutant-vs-TP53-NonMutant
3.136000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
